Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Royce Smaller-Companies Growth Fund Service Class (RYVPX)

12.56
Net Asset Value
+0.48%
1 Day
+14.08%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
1.51%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund's investment adviser invests the fund's assets primarily in equity securities of companies with stock market capitalizations up to $7.5 billion that Royce believes have above-average growth prospects. Normally, the fund invests at least 80% of its net assets in equity securities of companies with stock market capitalizations up to $7.5 billion. Although the fund normally focuses on securities of U.S. companies, it may invest up to 25% of its net assets (measured at the time of investment) in securities of companies headquartered in foreign countries.

Performance

1 month+5.72% 3 years+8.58%
3 months+2.45% 5 years+10.80%
1 year+22.79% Since inception+11.32%
Data through --

Peer Comparisonvs. Small growth

 RYVPXCategory
Performance 5-yr return+10.80%+12.81%
Expense ratio1.51%1.29%
Risk 5 year sharpe ratio0.810.92
Net assets$384.0M$944.4M
Average market cap$1.6B$3.5B
Average P/E29.229.9
Portfolio turnover59%59%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyRoyce
Fund manager & tenureJames (Chip) Skinner / 13 Years
Minimal initial investment$2,000.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock80.27%
International stock8.61%
Cash6.88%
Fixed income4.25%
Other0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 20.73%
Financial service 18.96%
Hardware 14.48%
Business service 11.16%
Consumer service 10.62%
Top 10 Holdings
Portfolio weighting
UIS Unisys Corp2.04%
TSC TriState Capital Holdings Inc1.78%
SUPN Supernus Pharmaceuticals Inc1.73%
QADA QAD Inc1.73%
-- 1.70%
SCOR Comscore Inc1.70%
-- 1.62%
CLVS Clovis Oncology Inc1.56%
IPGP IPG Photonics Corp1.52%
PLUS ePlus inc1.52%